Agenda


Click through to watch on demand.

Day 1 - 15 September

09:00

SHOWCASES AND VIRTUAL TECH DEMO BOOTHS (available all-day)

09:10

Executive panel: Finding, funding and building Europe’s next healthtech wave

  • What are the key opportunities for healthtech investors in the European ecosystem?
  • How has COVID-19 impacted the prospects of the European health-tech start up ecosystem? 
  • What does the future hold for European healthcare system transformation and how can investors support innovation to accelerate the process? 
Patrik Sobocki, Partner, Industrifonden
Josep Sanfeliu, Co-Founder and Managing Partner, Asabys Partners 
David Germonpré, Investment Partner, MTIP
Kamran Adle, Investor, Octopus Ventures
Michal Geva, Co-Founder and Managing Director, Triventures
Moderator: Peter Finnie, Partner, Potter Clarkson

 
10:00

1:1 PARTNERING AND INVESTABLE SHOWCASES (24 HRS)

10:30

Executive panel: Forging successful pharma-innovator partnerships

  • In which areas and verticals are pharma leveraging partnerships to bringing treatments and interventions to market? 
  • What are the key success factors for a pharma-innovator collaboration? Has COVID-19 caused pharma to fall back or double down on its commitment to digitisation?
  • Which verticals present the biggest opportunity for pharma to leverage innovation? 

Rachel Sha, Head of Digital BD and Licensing, Sanofi
Anders Dyhr Toft, Corporate Vice President Commercial Innovation, Novo Nordisk
Lauren Li, Head of Digital Health, Ipsen
Joel Krikston
, Head of Strategic Innovation Alliance, Merck Global Health Innovation Group

Moderator: Rachel Ford Hutman, Founder and CEO, Ford Hutman Media

12:00

Presentation: How does Roche engage Digital StartUps and Innovators?

  • Outlining Roche's approach and key focus areas to drive digital innovation in a collaborative effort
  • Existing initiatives such as Startup Creasphere
  • New Initiative - Starfinder Lab
Matthias Zach, Program Lead - Startup Creasphere, Digital Health Solutions CPS, Roche Diagnostics
Ravi Chana, Head of Business Development, Roche Diagnostics UK & Ireland, Roche Diagnostics
 
13:30

Executive panel: Transforming and reimagining healthcare

  • Health tech innovation has reached a climax over the last decade - how are the leaders of the world’s increasingly complex healthcare ecosystems respond?
  • Where are the hurdles holding back healthcare transformation, from value-alignment, adoption and reimbursement and sustainable commercial models?
  • Where is healthcare headed and which collaborations and realignments will be necessary to get us there?
Jeroen Tas, Chief Innovation Officer, Philips
Leila Shepherd, Director of Strategy, NHS Digital
Jennifer Esposito, VP Healthcare, Magic Leap 
Moderator: Russ Johannesson, CEO, Glooko
 
14:30

Presentation: Innovation and NHSX: The Transformation Agenda

  • NHSX - the context, and the story so far
  • Covid-19 - rapid response and deployment
  • Predictive prevention and the National Wellness Service - a concept
  • Joining up Social Care - a concept
  • Innovation Opportunities
  • Speeding up Innovation
Simon Eccles, National CCIO and Deputy CEO, NHSX
 
15:00

EXECUTIVE FORUM: Pharma Digital Leaders Forum  (1hr 40Mins)

The Pharma Digital Leaders Forum is an invite-only leaders’ roundtable forum, in which those leading the charge on digital transformation and innovation initiatives at global pharma share their experiences, discuss their collective challenges and look ahead at future developments and actionable outcomes.

15:15

Executive panel: Post Covid-19, is healthcare’s new normal digital?

  • Even before COVID-19 forced swathes of the global economy into shutdown, digital health was front and centre for healthcare and the life sciences -  how has the pandemic changed the picture? 
  • How are healthcare stakeholders re-evaluating their engagement with patients, members and clients?
  • Response efforts have been defined by unprecedented collaboration between key stakeholders; will these collaborations continue beyond the crisis into the world of post COVID-19 healthcare?
Jennifer Schneider, President, Livongo 
Mark Davies, Chief Medical Officer EMEA, IBM Watson Health
John Brownstein, Chief Innovation Officer, Boston Children’s Hospital
Jian Yang, Senior Director, Digital Health, Eli Lilly
Lisa Bookwalter, Director, Twitter Client Solutions, Health, Twitter
Moderator: Stan Kachnowski, Director Digital Health Program, Columbia Business School, and Chair, HITLAB
 
16:00

GOLD SHOWCASE SPOTLIGHT (10 Mins)

16:10

SILVER SHOWCASE SPOTLIGHT (10 Mins)

16:20

BRONZE SHOWCASE SPOTLIGHT (10 Mins)

16:30

VIRTUAL NETWORKING RECEPTION

Day 2 - 16 September

09:00

SHOWCASES AND VIRTUAL TECH DEMO BOOTHS (available all-day)

09:10

Executive panel: Is Healthtech still attractive to corporate venture capital?

  • How are corporate venture investors driving synergistic innovations across the healthcare value chain?
  • In light of the challenges currently facing healthtech start-ups, are corporate venture investors expanding into new areas, or consolidating existing portfolio focuses? 
  • How can healthtech SMEs demonstrate value to corporate investors in the current climate?
David Gordon, Head of Investments, Longliv Ventures 
Edward Kliphuis, Director, M Ventures 
Bruce Meadows, Investment Director, Takeda Digital Ventures
Tamir Meiri, Senior Manager Venture Investments, Johnson & Johnson Innovation – JJDC
Moderator: Tina Tan, Executive Editor, FirstWord Group
 
10:00

1:1 PARTNERING AND INVESTABLE SHOWCASES (24 HRS)

10:00

Presentation: How healthtech is thriving during the pandemic

  • How COVID-19 is pressing healthcare systems
  • The potential of digital health technology to help during a pandemic and how HealthTech is tackling COVID-19
  • How Investors have adjusted to the new reality of COVID-19

Piergiulio Lauriano, Partner, Alira Health

10:30

Executive panel: Incubating and accelerating innovation

  • The value incubators and accelerators offer to health-tech start-ups beyond capital - connections, guidance and commercial pathways.  

  • Where are the existing and emergent opportunities and challenges along the commercialisation journey?
  • Where and how should commercial leaders support early stage healthtech start-ups and SMEs?
Ben Maruthappu, CEO, Cera Care and Co-Founder, NHS Innovation Accelerator
Julia Belaya, Global Head of Business Development for Health, Plug and Play Tech Center
Sophie Park, Chief Strategist, Bayer G4A Digital Health Partnerships
Julia Hagen
, Director Politics and Regulatory, Health Innovation Hub
Moderator: Jan-Philipp Beck, CEO, EIT Health 

12:00

Presentation: Accelerating Digital Innovation within the Highly Regulated Biopharma Industry

  • How IT leaders and newer Digital leaders can partner to drive innovation
  • An ecosystem approach - integrating your platforms and IT systems with new tools like EHR
  • Buying versus building: What to build internally and where to partner externally
  • Addressing privacy, security and regulatory requirements in IT infrastructures

Kal Patel, CEO & Co-Founder, Bright Insight
Diana McKenzie, Board Member, Change Healthcare, MetLife, Vertex Pharmaceuticals

13:30

Executive panel: The Payer-Provider perspective on digital health partnerships and adoption

  • How important is buy-in from payers and providers in the adoption of digital health tools and technologies by health systems? 
  • From clinician workflows to alignment of financial and clinical value and reimbursement procedures -  crucial considerations for innovators looking for uptake
  • Payers and providers approaches to innovation, key success factors for integration into health systems
Rishi Das Gupta, Chief Innovation and Technology Officer, Royal Brompton and Harefield NHS Foundation Trust 
Eyal Zimlichman, Chief Medical and Innovation Officer, Sheba Medical Centre
Patti Barnett, VP Health Policy, Centene
Moderator: Laura Wamprecht, Managing Director, Flying Health 
 
 
14:30

Presentation: Path to FDA approval: Understanding and Optimizing FDA Pre- and Postmarket Cybersecurity Requirements for Medical Devices

  • Overview of Cybersecurity in Medical Devices
  • Quantifying Cybersecurity Risk
  • Board level Considerations
  • Corporate Risk Management
  • Investor Diligence

Jason Tugman, Associate Director, Cybersecurity Risk Management & Strategy, MCRA
Nicole Batista, Associate Director, Cardiovascular Regulatory Affairs, MCRA

15:15

Executive panel: Navigating the new healthtech funding landscape

  • After two record breaking years of digital health investment, deal-flow and commercial milestones, has innovation been hit by the COVID-19 pandemic? 
  • What effects has COVID-19 had on health-tech investment strategy and where are the opportunities for innovative solutions to emerge? 
  • Is the current crisis prompting a fundamental shift in favour of healthcare digitisation?
Anat Naschitz, Managing Director, Orbimed
Jessica Federer, Partner, Boston Millennia Partners
Steve Tolle, Partner, HLM Ventures
David Kim, Managing Partner, DigiTx Partners
Moderator: Adam Dakin, Managing Partner, Dreamit Ventures
 
16:00

GOLD SHOWCASE SPOTLIGHT

16:10

SILVER SHOWCASE SPOTLIGHT 

16:20

BRONZE SHOWCASE SPOTLIGHT 

16:30

INVESTOR SYNDICATION NETWORKING RECEPTION

 

Day 3 - 17 September

09:00

1:1 PARTNERING RE-OPENS (24 Hrs)


ON-DEMAND: ALL PANEL CONTENT FROM DAY 1 & 2 

ON-DEMAND: SHOWCASES AND VIRTUAL TECH DEMO BOOTHS (available all-day)

Day 4 - 18 September

09:00

1:1 PARTNERING RE-OPENS (24 Hrs)


ON-DEMAND: ALL PANEL CONTENT FROM DAY 1 & 2 

ON-DEMAND: SHOWCASES AND VIRTUAL TECH DEMO BOOTHS (available all-day)